Synageva BioPharma Corp. , a clinical stage biopharmaceutical company developing therapeutic products for rare diseases, will report 2012 fourth quarter and full year financial results after the NASDAQ Market closes on Monday, March 11, 2013.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130301005765&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130301005765&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment